Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2014 1
2015 1
2016 1
2017 2
2018 2
2019 2
2020 1
2021 1
2022 3
2023 6
2024 2
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study.
Atia O, Shavit-Brunschwig Z, Mould DR, Stein R, Matar M, Aloi M, Ledder O, Focht G, Urlep D, Hyams J, Broide E, Weiss B, Levine J, Russell RK, Turner D. Atia O, et al. Among authors: urlep d. Lancet Gastroenterol Hepatol. 2023 Jan;8(1):31-42. doi: 10.1016/S2468-1253(22)00307-7. Epub 2022 Oct 26. Lancet Gastroenterol Hepatol. 2023. PMID: 36306803
Upadacitinib for Induction of Remission in Pediatric Ulcerative Colitis: An International Multicenter Study.
Yerushalmy-Feler A, Spencer EA, Dolinger MT, Suskind DL, Mitrova K, Hradsky O, Conrad MA, Kelsen JR, Uhlig HH, Tzivinikos C, Ancona S, Wlazlo M, Hackl L, Shouval DS, Bramuzzo M, Urlep D, Olbjorn C, D'Arcangelo G, Pujol-Muncunill G, Yogev D, Kang B, Gasparetto M, Rungø C, Kolho KL, Hojsak I, Norsa L, Rinawi F, Sansotta N, Magen Rimon R, Granot M, Scarallo L, Trindade E, Velasco Rodríguez-Belvís M, Turner D, Cohen S. Yerushalmy-Feler A, et al. Among authors: urlep d. J Crohns Colitis. 2025 May 8;19(5):jjae182. doi: 10.1093/ecco-jcc/jjae182. J Crohns Colitis. 2025. PMID: 39605286
Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective Study.
Cohen S, Spencer EA, Dolinger MT, Suskind DL, Mitrova K, Hradsky O, Conrad MA, Kelsen JR, Uhlig HH, Tzivinikos C, Henderson P, Wlazlo M, Hackl L, Shouval DS, Bramuzzo M, Urlep D, Olbjørn C, D'Arcangelo G, Pujol-Muncunill G, Yogev D, Kang B, Gasparetto M, Rungoe C, Kolho KL, Hojsak I, Norsa L, Rinawi F, Sansotta N, Rimon RM, Granot M, Scarallo L, Trindade E, Rodríguez-Belvís MV, Turner D, Yerushalmy-Feler A. Cohen S, et al. Among authors: urlep d. Aliment Pharmacol Ther. 2025 Apr;61(8):1372-1380. doi: 10.1111/apt.70016. Epub 2025 Feb 8. Aliment Pharmacol Ther. 2025. PMID: 39921898 Free PMC article.
Effect of Overweight and Obesity on the Response to Anti-TNF Therapy and Disease Course in Children With IBD.
Sila S, Aloi M, Cucinotta U, Gianolio L, Granot M, Hradsky O, Hussey S, Kang B, Karoliny A, Kolho KL, de Laffolie J, Lega S, Matar M, Norsa L, Omiwole S, Orlanski-Meyer E, Palomino L, Rohani P, Scarallo L, Sladek M, Sohouli MH, Urlep D, Yerushalmy-Feler A, Zifman E, Hojsak I. Sila S, et al. Among authors: urlep d. Inflamm Bowel Dis. 2025 May 12;31(5):1263-1271. doi: 10.1093/ibd/izae165. Inflamm Bowel Dis. 2025. PMID: 39083286
Effectiveness and Safety of Adalimumab in Patients With Very Early-Onset Inflammatory Bowel Disease: A Retrospective Study on Behalf of the Porto Inflammatory Bowel Disease Working Group of European Society for Pediatric Gastroenterology Hepatology and Nutrition.
Weintraub Y, Collen LV, Hussey S, Mitrova K, Machta JS, Kang B, Granot M, D'Arcangelo G, Spencer EA, Kolho KL, Yeh PJ, Sladek M, Scarallo L, Palomino L, Afzal NA, de Laffolie J, Miele E, Bramuzzo M, Olén O, Russell RK, Rohani P, Tzivinikos C, Urlep D, van Rheenen PF, de Ridder L, Yogev D, Schneider AM, Cohen S, Garcia-Romero R, Dipasquale V, Uhlig HH, Shouval DS. Weintraub Y, et al. Among authors: urlep d. Inflamm Bowel Dis. 2025 Aug 1;31(8):2184-2194. doi: 10.1093/ibd/izae302. Inflamm Bowel Dis. 2025. PMID: 39813158
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study.
Atia O, Shavit-Brunschwig Z, Lev-Tzion R, Stein R, Broide E, Urlep D, Hyams J, Weiss B, Aloi M, Assa A, Gerasimidis K, Nichols B, Russell RK, Turner D. Atia O, et al. Among authors: urlep d. Lancet Gastroenterol Hepatol. 2025 Mar;10(3):234-247. doi: 10.1016/S2468-1253(24)00319-4. Epub 2025 Jan 6. Lancet Gastroenterol Hepatol. 2025. PMID: 39788134
Effectiveness and Safety of Ustekinumab in Pediatric Ulcerative Colitis: A Multi-center Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN.
Cohen S, Rolandsdotter H, Kolho KL, Turner D, Tzivinikos C, Bramuzzo M, Pujol-Muncunill G, Scarallo L, Urlep D, Rinawi F, Granot M, Kang B, Longueville Y, Rodríguez-Belvís MV, Weintraub Y, Navas-López VM, Yerushalmy-Feler A. Cohen S, et al. Among authors: urlep d. Paediatr Drugs. 2024 Sep;26(5):609-617. doi: 10.1007/s40272-024-00631-z. Epub 2024 May 23. Paediatr Drugs. 2024. PMID: 38780740 Free PMC article.
Endoscopic Balloon Dilatation in Pediatric Crohn Disease: An IBD Porto Group Study.
Ledder O, Viala J, Serban DE, Urlep D, De Ridder L, Martinelli M, Romano C, Church P, Griffiths C, Oliva S, Basude D, Sharma S, Thomson M. Ledder O, et al. Among authors: urlep d. J Pediatr Gastroenterol Nutr. 2023 Jul 1;77(1):62-69. doi: 10.1097/MPG.0000000000003783. Epub 2023 Mar 28. J Pediatr Gastroenterol Nutr. 2023. PMID: 36976584
27 results